Novel cannabidiol aspartame combination treatment (JW-100) significantly reduces ISGA score in atopic dermatitis: Results from a randomized double-blinded placebo-controlled interventional study.
Yanrui GaoYingfang LiYimei TanWei LiuSara OuaddiMcCoy JohnMaja KovacevicMirna SitumAndrija StanimirovicMarissa LiCarlos Gustavo WambierAndy GorenYing ZouPublished in: Journal of cosmetic dermatology (2021)
JW-100, a novel topical formulation containing CBD and aspartame, was demonstrated to produce statistically significant improvements in AD following 14 days of topical application.